Invoice-based recovery claims remain time-barred despite separate winding-up proceedings, absent valid acknowledgment or part-payment of the disputed ...
Extended limitation fails without specific suppression allegations, while overseas employee secondment remains taxable as manpower supply within norma...
Time-share accommodation classification excludes Club or Association Service where purchasers receive contractual occupancy rights without genuine mem...
CENVAT credit for trading requires reversal, while taxable-service rental credit remains proportionately available and limitation issues await resolut...
Vicarious liability for dishonoured company cheques may extend to non-signatory directors where complaints contain foundational responsibility avermen...
GST Council recommends formation of Group of Ministers to study GST on life and health insurance, and future of compensation cess. Exemption recommended for research and development services by government entities, universities using government or private grants. GST rates reduced from 12% to 5% on cancer drugs Trastuzumab Deruxtecan, Osimertinib and Durvalumab. GST rate on extruded/expanded savoury snacks reduced from 18% to 12%. Reverse Charge Mechanism introduced on metal scrap supply by unregistered to registered persons. GST clarified at 28% on car seats and roof-mounted air conditioning units for railways. Pilot rollout recommended for B2C e-invoicing. Enhancements like RCM ledger, ITC reclaim ledger and Invoice Management System to be introduced. Waiver of interest/penalty for tax demands in FY 2017-18 to 2019-20 u/s 128A recommended. Clarifications issued on various issues like refunds with concessional notifications, place of supply rules.
GST Council recommends formation of Group of Ministers to study GST on life and health insurance, and future of compensation cess. Exemption recommended for research and development services by government entities, universities using government or private grants. GST rates reduced from 12% to 5% on cancer drugs Trastuzumab Deruxtecan, Osimertinib and Durvalumab. GST rate on extruded/expanded savoury snacks reduced from 18% to 12%. Reverse Charge Mechanism introduced on metal scrap supply by unregistered to registered persons. GST clarified at 28% on car seats and roof-mounted air conditioning units for railways. Pilot rollout recommended for B2C e-invoicing. Enhancements like RCM ledger, ITC reclaim ledger and Invoice Management System to be introduced. Waiver of interest/penalty for tax demands in FY 2017-18 to 2019-20 u/s 128A recommended. Clarifications issued on various issues like refunds with concessional notifications, place of supply rules.
Note: It is a system-generated summary and is for quick reference only.